Current Pulmonology Reports

Scope & Guideline

Transforming knowledge into practice in respiratory medicine.

Introduction

Welcome to the Current Pulmonology Reports information hub, where our guidelines provide a wealth of knowledge about the journal’s focus and academic contributions. This page includes an extensive look at the aims and scope of Current Pulmonology Reports, highlighting trending and emerging areas of study. We also examine declining topics to offer insight into academic interest shifts. Our curated list of highly cited topics and recent publications is part of our effort to guide scholars, using these guidelines to stay ahead in their research endeavors.
LanguageEnglish
ISSN-
PublisherSPRINGER
Support Open AccessNo
Country-
Type-
Converge-
AbbreviationCURR PULMONOL REP / Curr. Pulmonol. Rep.
Frequency4 issues/year
Time To First Decision-
Time To Acceptance-
Acceptance Rate-
Home Page-
AddressONE NEW YORK PLAZA, SUITE 4600 , NEW YORK, NY 10004, UNITED STATES

Aims and Scopes

Current Pulmonology Reports serves as a comprehensive platform for disseminating the latest research findings and clinical practices in the field of pulmonary medicine. The journal emphasizes evidence-based approaches to diagnosis, treatment, and management of various respiratory diseases, while also incorporating innovative methodologies and emerging technologies.
  1. Pulmonary Oncology:
    The journal extensively covers advancements in the diagnosis and treatment of lung cancer, including imaging techniques, staging, and management strategies.
  2. Respiratory Diseases and Syndromes:
    Focus on a range of respiratory conditions such as obstructive sleep apnea, bronchiectasis, and interstitial lung diseases, providing in-depth reviews and clinical guidelines.
  3. Innovative Diagnostic and Therapeutic Techniques:
    Emphasis on novel methodologies including artificial intelligence applications in diagnostics, point-of-care ultrasound, and bronchoscopy techniques.
  4. Critical Care and Emergency Medicine:
    Research related to critical care practices in pulmonology, including the management of patients in acute respiratory distress and the role of echocardiography.
  5. Environmental and Occupational Lung Diseases:
    Exploration of the impact of environmental factors, such as air pollution and occupational exposures, on lung health and disease.
Recent publications in Current Pulmonology Reports highlight several emerging themes that reflect the evolving landscape of pulmonary medicine. These trends underscore the integration of technology and a more nuanced understanding of respiratory diseases.
  1. Artificial Intelligence in Pulmonology:
    A notable increase in research leveraging AI for diagnostic purposes, particularly in sleep apnea and radiology, indicates a shift towards technology-driven solutions.
  2. Point-of-Care Ultrasound:
    Growing emphasis on the standardization and application of point-of-care ultrasound in critical care settings, enhancing diagnostic efficiency and patient management.
  3. Impact of COVID-19 on Lung Health:
    Ongoing research into the long-term pulmonary effects of COVID-19, including interstitial lung abnormalities and management strategies for affected patients.
  4. Onco-Pulmonology:
    The intersection of oncology and pulmonology is gaining traction, with research exploring the implications of lung cancer treatments on pulmonary health and vice versa.
  5. Environmental Health and Lung Disease:
    An emerging focus on how environmental factors, including climate change and pollution, contribute to respiratory diseases, highlighting the need for interdisciplinary approaches.

Declining or Waning

While the journal consistently addresses a broad range of topics, certain areas of focus appear to be diminishing in prominence over recent years. This may reflect shifts in research priorities or the maturation of specific fields.
  1. Traditional Diagnostic Techniques:
    There seems to be a decline in publications centered on conventional diagnostic techniques, as newer technologies such as artificial intelligence and advanced imaging take precedence.
  2. Basic Research in Pulmonary Pathophysiology:
    Research focusing on fundamental aspects of lung disease pathophysiology has decreased, possibly overshadowed by clinical and applied research themes.
  3. General Reviews without Novel Insights:
    The journal is moving away from generic review articles that do not introduce novel perspectives or evidence, favoring more targeted and innovative studies.

Similar Journals

Annals of the American Thoracic Society

Connecting researchers and clinicians for a healthier tomorrow.
Publisher: AMER THORACIC SOCISSN: 1546-3222Frequency: 12 issues/year

Annals of the American Thoracic Society is a premier journal dedicated to advancing the field of pulmonary and respiratory medicine. Published by the American Thoracic Society, this journal offers an invaluable platform for researchers and clinicians to disseminate cutting-edge research, clinical insights, and innovative methodologies. With an impressive impact factor and ranked in the top Q1 category of its field (2023) and within the top 20 of 155 according to Scopus rankings, it is positioned as a leading force in shaping clinical practice and research directions. The journal's convergence years from 2013 to 2024 indicate a commitment to providing timely and relevant content at the forefront of pulmonary health. While not an open-access journal, it ensures broad accessibility to its significant contributions in respiratory medicine, making it an essential resource for professionals, researchers, and students alike endeavoring to deepen their understanding and improve outcomes in thoracic health.

Journal of Thoracic Disease

Connecting research and practice in thoracic health.
Publisher: AME PUBLISHING COMPANYISSN: 2072-1439Frequency: 12 issues/year

Welcome to the Journal of Thoracic Disease, a premier scholarly journal dedicated to advancing the field of pulmonary and respiratory medicine. Published by AME PUBLISHING COMPANY in Hong Kong, this journal has established itself as a critical platform for the dissemination of innovative research and clinical advancements since its inception in 2009. With an impressive Q2 ranking in the Scopus category of Pulmonary and Respiratory Medicine, it is recognized for its contribution to the academic community, featuring a broad range of original research, reviews, and case studies that address contemporary challenges in thoracic disease management. The journal is committed to Open Access principles, ensuring that high-quality research is readily available to a global audience, further enhancing its impact factor and reach. Researchers, healthcare professionals, and students alike will find invaluable insights within its pages, making Journal of Thoracic Disease an essential resource for those invested in the respiratory health domain.

EXPERIMENTAL LUNG RESEARCH

Advancing Insights in Pulmonary Science
Publisher: TAYLOR & FRANCIS INCISSN: 0190-2148Frequency: 10 issues/year

EXPERIMENTAL LUNG RESEARCH, published by Taylor & Francis Inc, is a pivotal journal within the field of pulmonary and respiratory medicine, with its extensive coverage spanning from 1980 to 2024. The journal is indexed with ISSN 0190-2148 and E-ISSN 1521-0499, marking its commitment to disseminating high-quality research. With its Category Quartile rankings falling within Q3 in Clinical Biochemistry, Molecular Biology, and Pulmonary and Respiratory Medicine as of 2023, EXPERIMENTAL LUNG RESEARCH serves as a crucial platform for researchers and professionals seeking to explore innovative findings and advancements in lung physiology, pathology, and therapeutic approaches. Although currently not Open Access, it offers substantial insights through rigorous peer-reviewed articles that contribute significantly to the scientific community's understanding of respiratory health. With Scopus rankings reflecting its relevance within its categories, this journal attracts a diverse readership interested in advancing the field of lung research.

Journal of Bronchology & Interventional Pulmonology

Exploring innovations in pulmonary interventions.
Publisher: LIPPINCOTT WILLIAMS & WILKINSISSN: 1944-6586Frequency: 4 issues/year

The Journal of Bronchology & Interventional Pulmonology, published by Lippincott Williams & Wilkins, is a vital periodical in the field of pulmonary and respiratory medicine, aiming to disseminate cutting-edge research, reviews, and clinical insights related to bronchial diseases and interventions. With an ISSN of 1944-6586 and E-ISSN 1948-8270, this journal has carved out a significant niche since its inception in 2009, continuing to publish innovative studies through 2024. Notably, it holds a respectable Q3 ranking in both the Medicine (miscellaneous) and Pulmonary & Respiratory Medicine categories as of 2023, indicating its growing influence in the academic community. Researchers and professionals worldwide benefit from the latest discoveries and clinical practices, enhancing their contributions to this essential area of healthcare. While the journal is not an open-access platform, its reputable standing and targeted content ensure that it remains a key resource for those dedicated to advancing knowledge in respiratory medicine. The journal’s address is located in Philadelphia, PA, further establishing it as a hub for medical research and innovation.

Thoracic Research and Practice

Transforming Knowledge into Practice for Better Lung Health
Publisher: AVESISSN: Frequency: 6 issues/year

Thoracic Research and Practice is an emerging open access journal published by AVES that aims to advance knowledge in the field of pulmonary and respiratory medicine. Launched in 2022, this journal aspires to provide a platform for innovative research, clinical practices, and advancements in thoracic health. With an E-ISSN of 2979-9139, it caters to a global audience while based in Turkey. Although it currently holds a Q4 category in the 2023 ranking within its field, the journal is dedicated to improving its standing through the inclusion of high-quality, original articles, systematic reviews, and case studies. As it converges years from 2023 to 2024, Thoracic Research and Practice invites researchers, professionals, and students to contribute valuable insights that aim to enhance patient outcomes and propel further exploration in this critical area of medicine.

SEMINARS IN RESPIRATORY AND CRITICAL CARE MEDICINE

Fostering Excellence in Critical Care Insights.
Publisher: THIEME MEDICAL PUBL INCISSN: 1069-3424Frequency: 6 issues/year

SEMINARS IN RESPIRATORY AND CRITICAL CARE MEDICINE is a leading journal published by THIEME MEDICAL PUBL INC, dedicated to advancing knowledge in the fields of respiratory and critical care medicine. Established in 1994, this esteemed publication has consistently provided a platform for researchers, healthcare professionals, and students to explore cutting-edge findings and comprehensive reviews encompassing both critical care and pulmonary domains. With a commendable impact factor and a 2023 ranking in the Q1 quartile for Critical Care and Intensive Care Medicine, as well as Q2 in Pulmonary and Respiratory Medicine, the journal stands out for its rigorous peer-review process and high-quality content. Although it does not operate under an open access model, its accessibility to various academic institutions ensures a broad reach across the medical community. By disseminating significant research, clinical insights, and critical updates, SEMINARS IN RESPIRATORY AND CRITICAL CARE MEDICINE serves as an essential resource for those aiming to stay at the forefront of their disciplines and enhance patient care outcomes.

REVUE DES MALADIES RESPIRATOIRES

Exploring the frontiers of respiratory medicine.
Publisher: MASSON EDITEURISSN: 0761-8425Frequency: 10 issues/year

REVUE DES MALADIES RESPIRATOIRES is a distinguished journal published by MASSON EDITEUR, focusing on the vital field of pulmonary and respiratory medicine. Established in 1984, this journal has become a prominent platform for sharing innovative research and clinical findings, reflecting an impressive array of studies that contribute to our understanding of respiratory diseases. With its ISSN 0761-8425 and E-ISSN 1776-2588, it facilitates access to scholarly work within the medical community, although it currently operates under a subscription model rather than Open Access. As indicated by its quartile ranking of Q4 in 2023 within its category and a Scopus rank of #128/155, REVUE DES MALADIES RESPIRATOIRES serves as an essential resource for researchers, professionals, and students aiming to stay informed about advancements in respiratory health. This journal plays a crucial role in fostering discussions that drive innovation and best practices in the treatment and understanding of respiratory conditions.

Lung India

Catalyzing change in pulmonary practices worldwide.
Publisher: WOLTERS KLUWER MEDKNOW PUBLICATIONSISSN: 0970-2113Frequency: 6 issues/year

Lung India is a premier open-access journal dedicated to the dissemination of high-quality research in the field of Pulmonary and Respiratory Medicine. Published by Wolters Kluwer Medknow Publications, it has been forging a path in respiratory healthcare since its inception in 2004. With its impactful contributions to clinical practice and research, Lung India holds a solid position in the academic landscape, evidenced by its ranking in the Q3 quartile for Pulmonary and Respiratory Medicine as of 2023, and its Scopus rank of #99 out of 155. The journal is particularly important for researchers, clinicians, and students in India and beyond, providing a platform for the latest findings and developments in respiratory care, lung disease management, and innovative treatment methods. With a commitment to accessibility, Lung India aims to promote knowledge sharing among professionals and support the advancement of respiratory health. The journal is well-equipped to cater to a diverse audience, ensuring that vital research is readily accessible and impactful.

Breathe

Transforming respiratory care through scholarly discourse.
Publisher: EUROPEAN RESPIRATORY SOC JOURNALS LTDISSN: 1810-6838Frequency: 4 issues/year

Breathe, published by the European Respiratory Society Journals Ltd, is a prominent open-access journal dedicated to advancing the field of pulmonary and respiratory medicine. With an ISSN of 1810-6838 and an E-ISSN of 2073-4735, this journal has been contributing to scholarly discourse since 2008. Nestled in the United Kingdom, it serves as a vital platform for researchers, clinicians, and educators, particularly in the areas of respiratory pathophysiology, diagnostic methods, and therapeutic interventions. Currently classified in the third quartile (Q3) for pulmonary and respiratory medicine, Breathe ranks 91st out of 155 in Scopus, reflecting its growing influence in the discipline. The journal aims to publish high-quality, peer-reviewed research that fosters collaboration and innovation in lung health, making significant strides toward improving patient outcomes. Whether you are a seasoned professional or an up-and-coming researcher, Breathe offers a wealth of knowledge and resources to support your work in this crucial area of medicine.

Respiratory Investigation

Transforming insights into impactful respiratory solutions.
Publisher: ELSEVIERISSN: 2212-5345Frequency: 6 issues/year

Respiratory Investigation is a leading peer-reviewed journal published by Elsevier, dedicated to advancing the field of Pulmonary and Respiratory Medicine. Since its inception in 2012, the journal has grown to become a vital resource for researchers, clinicians, and students alike, providing a platform for high-quality research articles, reviews, and clinical studies. With a commendable impact factor and ranked in the Q2 category of Scopus' 2023 metrics, it stands at rank #57 out of 155 in its field, illustrating its importance and influence within the academic community. Although the journal operates on a subscription basis, it remains committed to disseminating essential findings that enhance the understanding and treatment of respiratory diseases. Set against the innovative backdrop of the Netherlands, Respiratory Investigation not only serves as a conduit for scholarly exchange but also plays a critical role in shaping future research directions and clinical practices.